Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials

Ma, Z; Sun, XM; Zhang, Y; Li, H; Sun, D; An, ZL; Zhang, YH

An, ZL (通讯作者),Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharm, 8 Gongtinan Rd, Beijing 100020, Peoples R China.;Zhang, YH (通讯作者),Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Resp & Crit Care Med, Beijing 100020, Peoples R China.

THROMBOSIS AND HAEMOSTASIS, 2022; 122 (10): 1757

Abstract

Background The association between immune checkpoint inhibitors (ICIs) and thromboembolic events (TEEs) remains controversial. Objective The goal of t......

Full Text Link